Literature DB >> 9247977

Plasma levels of interleukin-6 and tumor necrosis factor alpha in chronic schizophrenia: effects of clozapine treatment.

P Monteleone1, M Fabrazzo, A Tortorella, M Maj.   

Abstract

Plasma levels of interleukin-6 (IL-6) and tumor necrosis factor alpha (TNF alpha) were assessed in 17 chronic schizophrenic patients who had been drug-free for 3 weeks and in 17 age- and sex-matched healthy subjects. Plasma concentrations of both cytokines were measured again in 12 patients after a 10-week treatment with clozapine. Compared with healthy controls, drug-free schizophrenic patients exhibited similar plasma IL-6 concentrations, but significantly higher levels of TNF alpha. After clozapine treatment, blood concentrations of TNF alpha fell to normal levels. These preliminary data support an immune activation in drug-free schizophrenic patients and an effect of clozapine on immune parameters.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9247977     DOI: 10.1016/s0165-1781(97)00036-x

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  22 in total

1.  Management of clozapine-induced fever in a child.

Authors:  David I Driver; Afsoon A Anvari; Christina M Peroutka; Rachna Kataria; Jerry Overman; David Lang; Maria Tietcheu; Reggie Parker; Keith Baptiste; Judith L Rapoport; Nitin Gogtay
Journal:  Am J Psychiatry       Date:  2014-04       Impact factor: 18.112

2.  Family and case-control association study of the tumor necrosis factor-alpha (TNF-alpha) gene with schizophrenia and response to antipsychotic medication.

Authors:  Gwyneth Zai; Daniel J Müller; Jan Volavka; Pal Czobor; Jeffrey A Lieberman; Herbert Y Meltzer; James L Kennedy
Journal:  Psychopharmacology (Berl)       Date:  2006-08-24       Impact factor: 4.530

3.  Interaction analysis between 5-HTTLPR and TNFA -238/-308 polymorphisms in schizophrenia.

Authors:  C-U Pae; A Serretti; P Artioli; T-S Kim; J-J Kim; C-U Lee; S-J Lee; I-H Paik; C Lee
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

4.  Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects.

Authors:  Brian J Miller; Peter Buckley; Wesley Seabolt; Andrew Mellor; Brian Kirkpatrick
Journal:  Biol Psychiatry       Date:  2011-06-08       Impact factor: 13.382

5.  Evaluating the Hypothesis That Schizophrenia Is an Inflammatory Disorder.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-11-05

6.  Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical Variables.

Authors:  Ellen E Lee; Suzi Hong; Averria Sirkin Martin; Lisa T Eyler; Dilip V Jeste
Journal:  Am J Geriatr Psychiatry       Date:  2016-10-17       Impact factor: 4.105

7.  Does Systemic Inflammation Play a Role in Pediatric Psychosis?

Authors:  Tatiana Falcone; Erin Carlton; Catherine Lee; Mattia Janigro; Vince Fazio; Fernando Espi Forcen; Kathleen Franco; Damir Janigro
Journal:  Clin Schizophr Relat Psychoses       Date:  2013-03-14

Review 8.  Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions.

Authors:  Brian J Miller; David R Goldsmith
Journal:  Neuropsychopharmacology       Date:  2016-09-22       Impact factor: 7.853

9.  Tumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44.

Authors:  V Saviouk; E W C Chow; A S Bassett; L M Brzustowicz
Journal:  Mol Psychiatry       Date:  2005-04       Impact factor: 15.992

10.  Serial mitogen-stimulated cytokine production from continuously ill patients with schizophrenia.

Authors:  Mark H Rapaport; Catherine Bresee
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.